| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,197 | 9,231 | 7,029 | 7,157 | | Cost of Revenue | (7,611) | 7,611 |
-
| (18,029) | | | Gross Profit | 18,808 | 1,620 | 7,029 | 25,185 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 17,270 | (666) | 6,482 | 24,677 | | Non Recurring |
-
|
-
|
-
| 2,288 | | Others | 46 | 46 | 46 | 45 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,492 | 2,240 | 501 | (1,825) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 308 | 43 | 117 | (101) | | Earnings Before Interest And Taxes | 1,800 | 2,283 | 618 | (2,587) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,800 | 2,283 | 618 | (2,587) | | Income Tax Expense | 207 | 458 | 169 | (907) | | Minority Interest | (741) | (1,112) | (46) | (661) | | | | Net Income From Continuing Ops | 852 | 713 | 403 | (1,680) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 852 | 713 | 403 | (1,680) | | Preferred Stock And Other Adjustments | (127) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $724 | $713 | $403 | ($1,680) |
|
0.51% Nasdaq 
Income Statement
